reported that CASZ1 was less expressed in hepatocellular cancer tissues, and it suppressed the abnormal proliferation of tumor cells by affecting MAPK/ERK signaling, MMP2 and MMP9 expression in vitro,14 which was not consistent with our findings. This evidence concerns the gene MMP9 and hepatocellular carcinoma.